Suchergebnisse - "Bonanno, Laura"

PubPharm (140)

1

The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients : the challenge is open for new therapeutic strategies

enthalten in: Critical reviews in oncology/hematology | 2024

von Ferro, A. | Marinato, G. | Mulargiu, C. | +4

2

Analysis of a Needs Assessment Survey to Develop an Online Resource Repository Supporting Nurse Anesthesia Educators

enthalten in: Nurse educator | 2024

von Lee, R. | Bonanno, L. | O'Sullivan, C. | +8

3

Summary of Research : Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

enthalten in: Targeted oncology | 2024

von Tsuboi, M. | Herbst, R. | John, T. | +18

4

Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer : Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World

enthalten in: The oncologist | 2024

von Pasello, G. | Lorenzi, M. | Scattolin, D. | +16

5

Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients

enthalten in: Journal of translational medicine | 2024

von Pasello, G. | Fabricio, A. | Del Bianco, P. | +15

6

Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients

enthalten in: Journal of translational medicine | 2024

von Pasello, G. | Fabricio, A. | Del Bianco, P. | +15

7

Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC

enthalten in: Targeted oncology | 2024

von Tsuboi, M. | Herbst, R. | John, T. | +18

8

Clinical evidence and adverse event management update of patients with RET- rearranged advanced non-small-cell lung cancer (NSCLC) treated with pralsetinib

enthalten in: Critical reviews in oncology/hematology | 2024

von Russo, G. | Bironzo, P. | Bennati, C. | +6

9

Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer : a multicentric analysis

enthalten in: Frontiers in immunology | 2024

von Bonanno, L. | Calvetti, L. | Dal Maso, A. | +10

10

Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline : insights from two case reports

enthalten in: Frontiers in oncology | 2024

von Bao, L. | Padovan, A. | Boscolo Bragadin, A. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[14]